RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling

Table 1 Correlation between clinicopathological characterastics and RPS7 expression of 60 HCC patients

characteristics	Numbers	Expression of RPS7		*p-value*
characteristics	Numbers	High (n=42)	Low (n=18)	*p-value*
Gender
male	48	33	15	0.999
female	12	9	3
Age
≤50	24	15	9	0.391
>50	36	27	9
AFP(ug/mL)
≤400	41	31	10	0.227
>400	19	11	8
Liver cirrhosis
positive	41	28	13	0.768
negative	19	14	5
Tumor size
≤5cm	25	16	9	0.409
>5cm	35	26	9
Tumor number
single	54	39	15	0.352
multiple	6	3	3
Encapsulation
complete	38	30	8	0.078
no	22	12	10
PVTT
yes	11	8	3	0.999
no	49	34	15
Microvascular invasion
yes	33	27	6	0.046*
no	27	15	12
Lung etastasis
yes	19	17	2	0.034*
no	41	25	16
TNM stage
I and II	25	13	12	0.021*
III and IV	35	29	6

Chi square test was used. AFP, α-fetoprotein; PVTT, Portal vein tumor thrombosis. *p-value< 0.05

ISSN: 1756-9966